Links to an increase in schizophrenia alone could wipe out any revenues from legalized pot, new study says
The white paper, co-authored by Christine Miller, Ph.D., a pharmacologist specializing in neuroscience, takes to task the major report used to support the legalization movement for failing to account for documented and well-researched links between marijuana use and mental health disorders, and the costs of treating them. To learn more, click to read the:
Press Release
Executive Summary
Marijuana Use and the Cost of Increased Schizophrenia